Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of CS-8958 (laninamivir) in Influenza Virus Infection Aged 10–19 Years
jRCT2080220784Phase 3
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of laninamivir in influenza (2 arms), sponsored by Daiichi Sankyo Co., Ltd.
02
Drugs
laninamivir
03
Conditions
influenza
Beyond the preview
Go deeper on jRCT2080220784.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220784.